blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0238189

EP0238189 - Verapamil dosage form [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.11.1991
Database last updated on 24.04.2024
Most recent event   Tooltip01.11.1991No opposition filed within time limitpublished on 27.12.1991 [1991/52]
Applicant(s)For all designated states
ALZA Corporation
950 Page Mill Road P.O. Box 10950 Palo Alto
California 94303-0802 / US
[N/P]
Former [1987/39]For all designated states
ALZA CORPORATION
950 Page Mill Road P.O. Box 10950
Palo Alto California 94303-0802 / US
Inventor(s)01 / Stephens, Sally I.
580 E. William Street
San Jose California 95112 / US
02 / Magruder, Paul
2762 Byron Street
Palo Alto California 94306 / US
03 / Wong, Patrick S.-L.
1371 Xavier Avenue
Hayward California 94545 / US
04 / Hamel, Larry G.
755 Ramona Avenue
Sunnyvale California 94087 / US
[1987/39]
Representative(s)Evans, David Charles, et al
fJ CLEVELAND 40-43, Chancery Lane
London, WC2A 1JQ / GB
[N/P]
Former [1987/39]Evans, David Charles, et al
F.J. CLEVELAND & COMPANY 40-43, Chancery Lane
London, WC2A 1JQ / GB
Application number, filing date87301155.510.02.1987
[1987/39]
Priority number, dateUS1986084114419.03.1986         Original published format: US 841144
[1987/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0238189
Date:23.09.1987
Language:EN
[1987/39]
Type: B1 Patent specification 
No.:EP0238189
Date:02.01.1991
Language:EN
[1991/01]
Search report(s)(Supplementary) European search report - dispatched on:EP13.07.1987
ClassificationIPC:A61K9/22
[1987/39]
CPC:
A61K31/275 (EP,KR,US); A61M31/00 (KR); A61K9/0004 (EP,US);
A61K9/20 (KR); A61P3/00 (EP); A61P9/08 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1987/39]
TitleGerman:Verpamil in Dosierungskapsel[1987/39]
English:Verapamil dosage form[1987/39]
French:Verapamil en capsule de diffusion[1987/39]
Examination procedure01.03.1988Examination requested  [1988/18]
17.07.1989Despatch of a communication from the examining division (Time limit: M04)
09.11.1989Reply to a communication from the examining division
22.03.1990Despatch of a communication from the examining division (Time limit: M02)
13.04.1990Reply to a communication from the examining division
23.05.1990Despatch of communication of intention to grant (Approval: Yes)
29.06.1990Communication of intention to grant the patent
09.07.1990Fee for grant paid
09.07.1990Fee for publishing/printing paid
Opposition(s)03.10.1991No opposition filed within time limit [1991/52]
Fees paidRenewal fee
09.02.1989Renewal fee patent year 03
02.02.1990Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0040899  (ALZA CORP [US]);
 [Y]GB2150830  (ALZA CORP);
 [A]EP0169105  (MERCK & CO INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.